Sickle-cell disease and the heart: Review of the current literature

British Journal of Haematology

Volumn 157, Issue 6, 2012, Pages 664-673

  Voskaridou, Ersi ^a   Christoulas, Dimitrios ^b   Terpos, Evangelos ^c  

^a LAIKO GENERAL HOSPITAL   (Greece)

^b 251 GENERAL AIR FORCE HOSPITAL   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Heart dysfunction; Iron overload; Myocardial ischaemia; Pulmonary hypertension; Sickle cell disease

Indexed keywords

ANGIOCARDIOGRAPHY; BLOOD TRANSFUSION; CARDIOMEGALY; CARDIOVASCULAR DISEASE; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; HEART DEATH; HEART INJURY; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HIGH OUTPUT HEART FAILURE; HUMAN; IRON OVERLOAD; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; SICKLE CELL ANEMIA; SUDDEN DEATH; THORAX PAIN;

ANEMIA, SICKLE CELL; BETA-GLOBINS; ERYTHROCYTES, ABNORMAL; HUMANS; HYPERTENSION, PULMONARY; IRON OVERLOAD; MYOCARDIAL ISCHEMIA; MYOCARDIUM;

EID: 84861531294     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2012.09143.x     Document Type: Review

References (112)

1. Adams, R.J. (2001) Stroke prevention and treatment in sickle cell disease. Archives of Neurology, 58, 565-568.
2. Almeida, A. & Roberts, I. (2005) Bone involvement in sickle cell disease. British Journal of Haematology, 129, 482-490.
3. Alpert, B.S., Gilman, P.A., Strong, W.B., Ellison, M.F., Miller, M.D., McFarlane, J. & Hayashidera, T. (1981) Hemodynamic and ECG response to exercise in children with sickle cell anemia. American Journal of Diseases of Children, 135, 362-366.
4. Anderson, L.J., Holden, S., Davis, B., Prescott, E., Charrier, C.C., Bunce, N.H., Firmin, D.N., Wonke, B., Porter, J., Walker, J.M. & Pennell, D.J. (2001) Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. European Heart Journal, 22, 2171-2179.
5. Arslankoylu, A.E., Hallioglu, O., Yilgor, E. & Duzovali, O. (2010) Assessment of cardiac functions in sickle cell anemia with Doppler myocardial performance index. Journal of Tropical Pediatrics, 56, 195-197.
6. Ashley-Koch, A.E., Elliott, L., Kail, M.E., De Castro, L.M., Jonassaint, J., Jackson, T.L., Price, J., Ataga, K.I., Levesque, M.C., Weinberg, J.B., Orringer, E.P., Collins, A., Vance, J.M. & Telen, M.J. (2008) Identification of genetic polymorphisms associated with risk for pulmonary hypertension in sickle cell disease. Blood, 111, 5721-5726.
7. Ataga, K.I. & Key, N.S. (2007) Hypercoagulability in sickle cell disease: new approaches to an old problem. Hematology/The Education Program of the American Society of Hematology, 9, 1-96.
8. Ataga, K.I., Sood, N., De Gent, G., Kelly, E., Henderson, A.G., Jones, S., Strayhorn, D., Lail, A., Lieff, S. & Orringer, E.P. (2004) Pulmonary hypertension in sickle cell disease. The American Journal of Medicine, 117, 665-669.
9. Ataga, K.I., Moore, C.G., Jones, S., Olajide, O., Strayhorn, D., Hinderliter, A. & Orringer, E.P. (2006) Pulmonary hypertension in patients with sickle cell disease: A longitudinal study. British Journal of Haematology, 134, 109-115.
10. Bahl, V.K., Malhotra, O.P., Kumar, D., Agarwal, R., Goswami, K.C., Bajaj, R. & Shrivastava, S. (1992) Noninvasive assessment of systolic and diastolic left ventricular function in patients with chronic severe anemia: a combined M-mode, two-dimensional, and Doppler echocardiographic study. American Heart Journal, 124, 1516-1523.
11. Balfour, I.C., Covitz, W., Davis, H., Rao, P.S., Strong, W.B. & Alpert, B.S. (1984) Cardiac size and function in children with sickle cell anemia. American Heart Journal, 108, 345-350.
12. Barnett, O., Saunders, D.E., McFarland, D.E. & Humphries, J.O. (1984) Myocardial infarction in sickle cell anemia. American Heart Journal, 16, 139-147.
13. Baroldi, C. (1969) High resistance of the human myocardium to shock and red blood cell aggregation (sludge). Cardiologia, 54, 271-277.
14. Bartfay, W.J. & Bartfay, E. (2000) Iron-overload cardiomyopathy: evidence for a free radical-mediated mechanism of injury and dysfunction in a murine model. Biological Research for Nursing, 2, 49-59.
15. Bode-Thomas, F., Hyacinth, H.I., Ogunkunle, O. & Omotoso, A. (2011) Myocardial ischaemia in sickle cell anaemia: evaluation using a new scoring system. Annals of Tropical Paediatrics, 31, 67-74.
16. Bosi, G., Crepaz, R., Gamberini, M.R., Fortini, M., Scarcia, S., Bonsante, E., Pitscheider, W. & Vaccari, M. (2003) Left ventricular remodelling, and systolic and diastolic function in young adults with thalassaemia major: a Doppler echocardiographic assessment and correlation with haematological data. Heart, 89, 762-766.
17. Buja, L.M. & Roberts, W.C. (1971) Iron in the heart. Etiology and clinical significance. The American Journal of Medicine, 51, 209-221.
18. Bunn, H.F. (1997) Pathogenesis and treatment of sickle cell disease. New England Journal of Medicine, 337, 762-769.
19. Caldas, M.C., Meira, Z.A. & Barbosa, M.M. (2008) Evaluation of 107 patients with sickle cell anemia through tissue Doppler and myocardial performance index. Journal of the American Society of Echocardiography, 21, 1163-1167.
20. Castro, O., Hoque, M. & Brown, B.D. (2003) Pulmonary hypertension in sickle cell disease: Cardiac catheterization results and survival. Blood, 101, 1257-1261.
21. Charache, S., Lubn, B. & Reid, C. (1992) Management and therapy of sickle cell disease. NIH Publication, 92, 2117.
22. Chun, S., Vsami, S. & Bertles, J. (1970) Abnormal rheology of oxygenated blood in sickle cell anemia. The Journal of Clinical Investigation, 49, 623-634.
23. Claster, S. & Vichinsky, E.P. (2003) Managing sickle cell disease. BMJ, 327, 1151-1155.
24. Colombatti, R., Maschietto, N., Varotto, E., Grison, A., Grazzina, N., Meneghello, L., Teso, S., Carli, M., Milanesi, O. & Sainati, L. (2010) Pulmonary hypertension in sickle cell disease children under 10 years of age. British Journal of Haematology, 150, 601-609.
25. Covarrubias, E.A., Sheikh, M.U., Solanki, D.L., Morjaria, M. & Fox, L.M. (1980) Left ventricular function in sickle cell anemia: a noninvasive evaluation. Southern Medical Journal, 73, 342-344.
26. Covitz, W., Espeland, M., Gallagher, D., Hellenbrand, W., Leff, S. & Talner, N. (1995) The heart in sickle cell anemia; The Cooperative Study of Sickle Cell Disease (CSSCD). Chest, 108, 1214-1219.
27. Dang, N.C., Johnson, C., Eslami-Farsani, M. & Haywood, L.J. (2005) Myocardial injury or infarction associated with fat embolism in sickle cell disease: a report of three cases with survival. American Journal of Hematology, 80, 133-136.
28. Darbari, D.S., Kple-Faget, P., Kwagyan, J., Rana, S., Gordeuk, V.R. & Castro, O. (2006) Circumstances of death in adult sickle cell disease patients. American Journal of Hematology, 81, 858-863.
29. Davis, B.A., O'Sullivan, C., Jarritt, P.H. & Porter, J.B. (2004) Value of sequential monitoring of left ventricular ejection fraction in the management of thalassemia major. Blood, 104, 263-269.
30. De Castro, L.M., Jonassaint, J.C., Graham, F.L., Ashley-Koch, A. & Telen, M.J. (2008) Pulmonary hypertension associated with sickle cell disease: Clinical and laboratory endpoints and disease outcomes. American Journal of Hematology, 83, 19-25.
31. De Caterina, R., Libby, P., Peng, H.B., Thannickal, V.J., Rajavashisth, T.B., Gimbrone, Jr, M.A., Shin, W.S. & Liao, J.K. (1995) Nitric oxide decreases cytokineinduced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. The Journal of Clinical Investigation, 96, 60-68.
32. De Montalembert, M., Maunoury, C., Acar, P., Brousse, V., Sidi, D. & Lenoir, G. (2004) Myocardial ischaemia in children with sickle cell disease. Archives of Disease in Childhood, 89, 359-362.
33. Emre, U., Miller, S.T., Gutierez, M., Steiner, P., Rao, S.P. & Rao, M. (1995) Effect of transfusion in acute chest syndrome of sickle cell disease. The Journal of Pediatrics, 127, 901-904.
34. Fontaine, J.M., Ofili, E.O., Adenaike, M.B., VanDecker, W. & Haywood, L.J. (2008) Clinical assessment of the risk for sudden cardiac death in patients with sickle cell anemia. Journal of the National Medical Association, 100, 360-368.
35. Furchgott, R.F. & Zawadzki, J.V. (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 288, 373-376.
36. Gerry, J.L., Baird, M.G. & Fortuin, N.J. (1976) Evaluation of left ventricular function in patients with sickle cell anemia. The American Journal of Medicine, 60, 968-972.
37. Gerry, J.L., Bulkley, B.H. & Hutchins, G.M. (1978) Clinicopathologic analysis of cardiac dsyfunction in 52 patients with sickle cell anemia. The American Journal of Cardiology, 42, 211-216.
38. Ghoti, H., Goitein, O., Koren, A., Levin, C., Kushnir, T., Rachmilewitz, E. & Konen, E. (2010) No evidence for myocardial iron overload and free iron species in multitransfused patients with sickle/beta-thalassaemia. European Journal of Haematology, 84, 59-63.
39. Ghugre, N.R., Enriquez, C.M., Gonzalez, I., Nelson, Jr, M.D., Coates, T.D. & Wood, J.C. (2006) MRI detects myocardial iron in the human heart. Magnetic Resonance in Medicine, 56, 681-686.
40. Gladwin, M.T. & Vichinsky, E. (2008) Pulmonary complications of sickle cell disease. The New England Journal of Medicine, 359, 2254-2265.
41. Gladwin, M.T., Sachdev, V., Jison, M.L., Shizukuda, Y., Plehn, J.F., Minter, K., Brown, B., Coles, W.A., Nichols, J.S., Ernst, I., Hunter, L.A., Blackwelder, W.C., Schechter, A.N., Rodgers, G.P., Castro, O. & Ognibene, F.P. (2004) Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. The New England Journal of Medicine, 350, 886-895.
42. Hall, C. (2004) Essential biochemistry and physiology of (NT-pro)BNP. European Journal of Heart Failure, 6, 257-260.
43. Hankins, J.S., McCarville, M.B., Hillenbrand, C.M., Loeffler, R.B., Ware, R.E., Song, R., Smeltzer, M.P. & Joshi, V. (2010) Ventricular diastolic dysfunction in sickle cell anemia is common but not associated with myocardial iron deposition. Pediatric Blood & Cancer, 55, 495-500.
44. Harlan, J.M. (2000) Introduction: anti-adhesion therapy in sickle cell disease. Blood, 95, 365-367.
45. Hebbel, R.P. (1997) Adhesive interactions of sickle erythrocytes with endothelium. The Journal of Clinical Investigation, 100, S83-S86.
46. Hebbel, R.P., Schwartz, R.S. & Mohandas, N. (1985) The adhesive sickle erythrocyte: Cause and consequence of abnormal interactions with endothelium, monocytes/macrophages and model membranes. Clinics in Haematology, 14, 141-161.
47. Hossein-Nia, M., Nisbet, J., Merton, G.K. & Holt, D.W. (1995) Spurious rises of cardiac troponin T. Lancet, 346, 1558.
48. Ignarro, L.J., Byrns, R.E., Buga, G.M. & Wood, K.S. (1987) Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circulation Research, 61, 866-879.
49. Inati, A., Musallam, K.M., Wood, J.C., Sheikh-Taha, M., Daou, L. & Taher, A.T. (2009) Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease. European Journal of Haematology, 83, 565-571.
50. James, T.N. (2000) Homage to James B. Herrick: a contemporary look at myocardial infarction and at sickle-cell heart disease: the 32nd Annual Herrick Lecture of the Council on Clinical Cardiology of the American Heart Association. Circulation, 101, 1874-1899.
51. James, T.N., Riddick, L. & Massing, G.K. (1994) Sickle cells and sudden death: morphologic abnormalities of the cardiac conduction system. The Journal of Laboratory and Clinical Medicine, 124, 507-520.
52. Johnson, M.C., Kirkham, F.J., Redline, S., Rosen, C.L., Yan, Y., Roberts, I., Gruenwald, J., Marek, J. & DeBaun, M.R. (2010) Left ventricular hypertrophy and diastolic dysfunction in children with sickle cell disease are related to asleep and waking oxygen desaturation. Blood, 116, 16-21.
53. Karayalcin, G., Rosner, F., Kim, K.Y., Chandra, P. & Aballi, A.J. (1975) Sickle cell anemia-clinical manifestations in 100 patients and review of the literature. The American Journal of the Medical Sciences, 269, 51-68.
54. Kato, G.J. (2008) Novel small molecule therapeutics for sickle cell disease: Nitric oxide, carbon monoxide, nitrite, and apolipoprotein a-I. Hematology/the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, 2008, 186-192.
55. Kato, G.J. & Gladwin, M.T. (2008) Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy. JAMA: The Journal of the American Medical Association, 300, 2638-2646.
56. Kato, G.J., McGowan, V., Machado, R.F., Little, J.A., Taylor, J. 6th, Morris, C.R., Nichols, J.S., Wang, X., Poljakovic, M., Morris, Jr, S.M. & Gladwin, M.T. (2006) Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension and death in patients with sickle cell disease. Blood, 107, 2279-2285.
57. Kato, G.J., Gladwin, M.T. & Steinberg, M.H. (2007) Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Reviews, 21, 37-47.
58. Kaul, D.K., Fabry, M.E. & Nagel, R.L. (1989) Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: Pathophysiological implications. Proceedings of the National Academy of Sciences of the United States of America, 86, 3356-3360.
59. Lamers, L., Ensing, G., Pignatelli, R., Goldberg, C., Bezold, L., Ayres, N. & Gajarski, R. (2006) Evaluation of left ventricular systolic function in pediatric sickle cell anemia patients using the end-systolic wall stress-velocity of circumferential fiber shortening relationship. Journal of the American College of Cardiology, 47, 2283-2288.
60. Lau, K.C., Li, A.M., Hui, P.W. & Yeung, C.Y. (1989) Left ventricular function in beta thalassemia major. Archives of Disease in Childhood, 64, 1046-1051.
61. Lester, L.A., Sodt, P.C., Hutcheon, N. & Arcilla, R.A. (1990) Cardiac abnormalities in children with sickle cell anemia. Chest, 98, 1169-1174.
62. Lewis, B.S., Lewis, N., Dagan, I., Rachmilewitz, E.A., Gotsman, M.S. & Sapoznikov, D. (1982) Studies of left ventricular function in anemia due to beta-thalassemia. Israel Journal of Medical Sciences, 18, 928-934.
63. Lima, C.S., Ueti, O.M., Ueti, A.A., Franchini, K.G., Costa, F.F. & Saad, S.T. (2008) Enalapril therapy and cardiac remodelling in sickle cell disease patients. Acta Cardiologica, 63, 599-602.
64. Lindsay, Jr, J., Meshel, J.C. & Patterson, R.H. (1974) The cardiovascular manifestations of sickle cell disease. Archives of Internal Medicine, 133, 643-651.
65. Liu, P. & Olivieri, N. (1994) Iron overload cardiomyopathies: new insights into an old disease. Cardiovascular Drugs and Therapy, 8, 101-110.
66. Lombardo, T., Rosso, R., La Ferla, A., Ferro, M.G., Ximenes, B., Frontini, V. & Pennisi, S. (2003) Acute Chest Syndrome: the role of erythro-exchange in patients with sickle cell disease in Sicily. Transfusion and Apheresis Science, 29, 39-44.
67. Machado, R.F., Anthi, A., Steinberg, M.H., Bonds, D., Sachdev, V., Kato, G.J., Taveira-DaSilva, A.M., Ballas, S.K., Blackwelder, W., Xu, X., Hunter, L., Barton, B., Waclawiw, M., Castro, O. & Gladwin, M.T. (2006) N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease. JAMA: The Journal of the American Medical Association, 296, 310-318.
68. Machado, R., Hildesheim, M., Mendelsohn, L., Remaley, A., Kato, G.J. & Gladwin, M.T. (2011) NT-pro brain natriuretic peptide levels and the risk of death in the cooperative study of sickle cell disease. British Journal of Haematology, 154, 512-520.
69. Martin, C.R., Johnson, C.S., Cobb, C., Tatter, D. & Haywood, L.J. (1996) Myocardial infarction in sickle cell disease. Journal of the National Medical Association, 88, 428-432.
70. McCormick, W.F. (1988) Massive nonatherosclerotic myocardial infarction in sickle cell anemia. The American Journal of Forensic Medicine and Pathology, 9, 151-154.
71. Mendis, S., Thygesen, K., Kuulasmaa, K., Giampaoli, S., Mähönen, M., Ngu Blackett, K. & Lisheng, L. (2011) World Health Organization definition of myocardial infarction: 2008-09 revision. International Journal of Epidemiology, 40, 139-146.
72. Morris, C.R., Kato, G.J., Poljakovic, M., Wang, X., Blackwelder, W.C., Sachdev, V., Hazen, S.L., Vichinsky, E.P., Morris, Jr, S.M. & Gladwin, M.T. (2005) Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension and mortality in sickle cell disease. JAMA: The Journal of the American Medical Association, 294, 81-90.
73. Oguanobi, N.I., Ejim, E.C., Anisiuba, B.C., Onwubere, B.J., Ike, S.O. & Ibegbulam, O.G. (2012) Electrocardiographic findings in sickle cell cardiovascular autonomic neuropathy. Clinical Autonomic Research, In press (DOI: 10.1007/s10286-011-0156-0).
74. Ohene-Frempong, K. (2001) Indications for red cell transfusion in sickle cell disease. Seminars in Hematology, 38, 5-13.
75. Oliveira, E. & Gomez-Patino, N. (1963) Falcemic cardiopathy: report of a case. The American Journal of Cardiology, 11, 686-688.
76. Olnes, M., Chi, A., Haney, C., May, R., Minniti, C., Taylor, J.6th. & Kato, G.J. (2009) Improvement in hemolysis and pulmonary arterial systolic pressure in adult patients with sickle cell disease during treatment with hydroxyurea. American Journal of Hematology, 84, 530-532.
77. Olson, L.J., Edwards, W.D., McCall, J.T., Ilstrup, D.M. & Gersh, B.J. (1987) Cardiac iron deposition in idiopathic hemochromatosis: histologic and analytic assessment of 14 hearts from autopsy. Journal of the American College of Cardiology, 10, 1239-1243.
78. Oudit, G.Y., Trivieri, M.G., Khaper, N., Liu, P.P. & Backx, P.H. (2006) Role of L-type Ca2 + channels in iron transport and ironoverloaded cardiomyopathy. Journal of Molecular Medicine, 84, 349-364.
79. Palmer, R.M., Ashton, D.S. & Moncada, S. (1988) Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature, 333, 664-666.
80. Panza, J.A., Casino, P.R., Kilcoyne, C.M. & Quyyumi, A.A. (1993) Role of endotheliumderived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation, 87, 1468-1474.
81. Papanikolaou, G., Tzilianos, M., Christakis, J.I., Bogdanos, D., Tsimirika, K., MacFarlane, J., Goldberg, Y.P., Sakellaropoulos, N., Ganz, T. & Nemeth, E. (2005) Hepcidin in iron overload disorders. Blood, 105, 4103-4105.
82. Parent, F., Bachir, D., Inamo, J., Lionnet, F., Driss, F., Loko, G., Habibi, A., Bennani, S., Savale, L., Adnot, S., Maitre, B., Yaïci, A., Hajji, L., O'Callaghan, D.S., Clerson, P., Girot, R., Galacteros, F. & Simonneau, G. (2011) A hemodynamic study of pulmonary hypertension in sickle cell disease. The New England Journal of Medicine, 365, 44-53.
83. Pashankar, F.D., Carbonella, J., Bazzy-Asaad, A. & Friedman, A. (2009) Longitudinal follow up of elevated pulmonary artery pressures in children with sickle cell disease. British Journal of Haematology, 144, 736-741.
84. Porter, J.B. (2009) Pathophysiology of transfusional iron overload: contrasting patterns in thalassemia major and sickle cell disease. Hemoglobin, 33, S37-45.
85. Powars, D.R. (1990) Sickle cell anemia and major organ failure. Hemoglobin, 14, 573-598.
86. Quinlan, G.J., Evans, T.W. & Gutteridge, J.M. (2002) Iron and the redox status of the lungs. Free Radical Biology & Medicine, 33, 1306-1313.
87. Raman, S.V., Simonetti, O.P., Cataland, S.R. & Kraut, E.H. (2006) Myocardial ischemia and right ventricular dysfunction in adult patients with sickle cell disease. Haematologica, 91, 1329-1335.
88. Rees, D.C., Williams, T.N. & Gladwin, M.T. (2010) Sickle-cell disease. Lancet, 376, 2018-2031.
89. Reiter, C.D. & Gladwin, M.T. (2003) An emerging role for nitric oxide in sickle cell disease vascular homeostasis and therapy. Current Opinion in Hematology, 10, 99-107.
90. Reiter, C.D., Wang, X., Tanus-Santos, J.E., Hogg, N., Cannon, R.O.3rd., Schechter, A.N. & Gladwin, M.T. (2002) Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nature Medicine, 8, 1383-1389.
91. Romero Mestre, J.C., Hernández, A., Agramonte, O. & Hernández, P. (1997) Cardiovascular autonomic dysfunction in sickle cell anemia: a possible risk factor for sudden death? Clinical Autonomic Research, 7, 121-125.
92. Saad, S.T., Arruda, V.R., Junqueira, O.O., Schelini, F.A. & Coelho, O.B. (1990) Acute myocardial infarction in sickle cell anemia associated wvith severe hypoxia. Postgraduate Medical Journal, 66, 1068-1070.
93. Sachdev, V., Machado, R.F., Shizukuda, Y., Rao, Y.N., Sidenko, S., Ernst, I., St Peter, M., Coles, W.A., Rosing, D.R., Blackwelder, W.C., Castro, O., Kato, G.J. & Gladwin, M.T. (2007) Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease. Journal of the American College of Cardiology, 49, 472-479.
94. San, M., Demitrtas, M., Burgut, R., Birand, A. & Baslamish, F. (1998) Left ventricular systolic and diastolic functions in patients with sickle cell anemia. International Angiology: A Journal of the International Union of Angiology, 7, 185-187.
95. Schtulman, L.N., BraunNvald, E. & Rosenthal, D.S. (1997) Hematological-oncological disorders and heart disease. In: Heart Disease: A Textbook of Cardiovascular Medicine, 5th edn (eds by E. Braunwald), pp. 1787-1788. WAB Saunders Company, Philadelphia.
96. Shah, F.T., Westwood, M.A., Evans, P.J. & Porter, J.B. (2002) Discordance in MRI assessment in iron distribution and plasma NTBI between transfusionally iron loaded adults with sickle cell and thalassemia. Blood, 100, abstract 668a.
97. Sharpe, C.C. & Thein, S.L. (2011) Sickle cell nephropathy - a practical approach. British Journal of Haematology, 155, 287-297.
98. Stein, B.C. & Levin, R.I. (1998) Natriuretic peptides: physiology, therapeutic potential, and risk stratification in ischemic heart disease. American Heart Journal, 135, 914-923.
99. Sullivan, K.J., Goodwin, S.R., Evangelist, J., Moore, R.D. & Mehta, P. (1999) Nitric oxide successfully used to treat acute chest syndrome of sickle cell disease in a young adolescent. Critical Care Medicine, 27, 2563-2568.
100. Telen, M.J. (2001) Principles and problems of transfusion in sickle cell disease. Seminars in Hematology, 38, 315-323.
101. Vichinsky, E.P., Neumayr, L.D., Earles, A.N., Williams, R., Lennette, E.T., Dean, D., Nickerson, B., Orringer, E., McKie, V., Bellevue, R., Daeschner, C. & Manci, E.A. (2000) Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. The New England Journal of Medicine, 342, 1855-1865.
102. Voskaridou, E., Tsetsos, G., Tsoutsias, A., Spyropoulou, E., Christoulas, D. & Terpos, E. (2007) Pulmonary hypertension in patients with sickle cell/b thalassemia: incidence and correlation with serum N-terminal pro-brain natriuretic peptide concentrations. Haematologica, 92, 738-743.
103. Walter, P.B., Fung, E.B., Killilea, D.W., Jiang, Q., Hudes, M., Madden, J., Porter, J., Evans, P., Vichinsky, E. & Harmatz, P. (2006) Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease. British Journal of Haematology, 135, 254-263.
104. Wayne, A.S., Kevy, S.V. & Nathan, D.G. (1993) Transfusion management of sickle cell disease. Blood, 81, 1109-1123.
105. Westwood, M.A., Shah, F., Anderson, L.J., Strange, J.W., Tanner, M.A., Maceira, A.M., Howard, J., Porter, J.B., Walker, J.M., Wonke, B. & Pennell, D.J. (2007) Myocardial tissue characterization and the role of chronic anemia in sickle cell cardiomyopathy. Journal of Magnetic Resonance Imaging, 26, 564-568.
106. Wethers, D.L. (2000) Sickle cell disease in childhood: part II. Diagnosis and treatment of major complications and recent advances in treatment. American Family Physician, 62, 1309-1314.
107. Wood, J.C., Enriquez, C., Ghugre, N., Otto-Duessel, M., Aguilar, M., Nelson, M.D., Moats, R. & Coates, T.D. (2005a) Physiology and pathophysiology of iron cardiomyopathy in thalassemia. Annals of the New York Academy of Sciences, 1054, 386-395.
108. Wood, J.C., Otto-Duessel, M., Aguilar, M., Nick, H., Nelson, M.D., Coates, T.D., Pollack, H. & Moats, R. (2005b) Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy. Circulation, 112, 535-545.
109. Woodruff, A.W. (1970) Sickle cell anaemia with complicating coronary infarction. Proceedings of the Royal Society of Medicine, 63, 1314.
110. Yater, W.M. & Hansmann, G.H. (1936) Sickle-cell anemia: A new cause of cor pulmonale: Report of two cases with numerous disseminated occlusions of the small pulmonary arteries. The American Journal of the Medical Sciences, 191, 474-484.
111. Yu, B., Raher, M.J., Volpato, G.P., Bloch, K.D., Ichinose, F. & Zapol, W.M. (2008) Inhaled nitric oxide enables artificial blood transfusion without hypertension. Circulation, 117, 1982-1990.
112. Zorca, S., Freeman, L., Hildesheim, M., Allen, D., Remaley, A.T., Taylor, J.G. & Kato, G.J. (2010) Lipid levels in sickle-cell disease associated with haemolytic severity, vascular dysfunction and pulmonary hypertension. British Journal of Haematology, 149, 436-445.